Russian Official Calls for Legislation Banning E-Cigarettes for Health Reasons

Regulations by 2FIRSTS.ai
Jul.30.2024
Russian Official Calls for Legislation Banning E-Cigarettes for Health Reasons
Russian official Vitaly Milonov calls for legislative ban on e-cigarettes, citing health risks and widespread availability.

According to Gazeta, on July 29th, Vitaly Milonov, Deputy Chairman of the State Duma Committee on Family, Protection of Children's Rights, Motherhood, and Fatherhood in Russia, proposed that e-cigarettes should be banned at the legislative level. He believes that the widespread use of e-cigarettes is like a plague and warns of its harmful effects on health.


Milonov emphasized in the NSN news center: "Our country has entered an e-cigarette epidemic, with these products being sold in every corner." He pointed out that currently there is no clear research showing the specific health damages caused by e-cigarettes, but there are some concerning signals emerging. Milonov believes the main issue is that people become addicted to e-cigarettes faster, despite the fact that the smell of e-cigarettes is not as unpleasant as regular cigarettes, they can lead smokers to quickly become dependent on "large amounts of nicotine.


Previously, doctors warned that the "spice" (synthetic cannabinoids) and heavy metals in e-cigarettes have carcinogenic effects on the endocrine glands. E-cigarette vapor contains over 30 dangerous substances, many of which, such as propylene glycol, can accumulate in the body, causing allergies and producing purulent infections, damaging liver and kidney function.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Canada: “I Want My Pouches” launches during National Non-Smoking Week to push easier adult access to nicotine pouches
Canada: “I Want My Pouches” launches during National Non-Smoking Week to push easier adult access to nicotine pouches
Canadian consumer advocacy group I Want My Pouches announced its launch during National Non-Smoking Week, calling for straightforward, consistent and practical adult access to nicotine pouches.
Jan.22 by 2FIRSTS.ai
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
HB 5437 “Vape Safety Act” advances in House committee, proposing statewide licensing for vape shops
HB 5437 “Vape Safety Act” advances in House committee, proposing statewide licensing for vape shops
A committee substitute for House Bill 5437, the Vape Safety Act sponsored by Del. David McCormick (David McCormick), was recommended Monday afternoon by the House Health and Human Resources Committee to the full House, with the bill next heading to the House Judiciary Committee. HB 5437 would require specialty shops selling tobacco, tobacco-derived products, alternative nicotine, or vapor products and accessories to obtain a state license from the Alcohol Beverage Control Administration (ABCA)
Feb.26 by 2FIRSTS.ai
PMI AI White Paper Warns of “Cognitive Atrophy” and Attention Erosion, Calls for Focus on Human Cognition’s Evolution
PMI AI White Paper Warns of “Cognitive Atrophy” and Attention Erosion, Calls for Focus on Human Cognition’s Evolution
Philip Morris International (PMI) has released a white paper calling for cross-sector dialogue on how AI may affect human cognitive abilities. The paper flags risks including “cognitive atrophy” and attention erosion, and warns of a widening cognitive divide and rising pressures on information verification and trust.
Jan.21 by 2FIRSTS.ai
Russia’s Rostov Region Eyes Full Vape Sales Ban, Signals Tighter Tobacco Retail Rules
Russia’s Rostov Region Eyes Full Vape Sales Ban, Signals Tighter Tobacco Retail Rules
Russia’s Rostov region is preparing to pursue a region-wide ban on vape sales and is also signaling support for broader regional powers to tighten tobacco retail rules. A regional lawmaker said the initiative aligns with a State Duma bill that would allow regions to impose vape sales bans—an initiative he said has presidential backing.
Jan.28 by 2FIRSTS.ai
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11